NTRR: Huge Opportunities For Innovation Loom In Billion Dollar Cannabis Markets

Even as lucrative new markets for medical marijuana continue to open up across North America, in many cases, patients don’t know much more about the cannabis they’re buying and consuming than the name of the strain. Neutra Corp. (OTCBB: NTRR) is exploring ways to change that.

Currently, the medical marijuana market in the U.S. is worth $1.7 billion. With more cannabis legislation now on the table from coast to coast, most industry experts agree that figure will rise. NTRR is looking for new technologies that will put the company on the cutting edge of cannabis-related products and services.

In order for patients to achieve consistent results with medical marijuana, they must know the potency of the drug’s active ingredients, including THC, cannabidiol (CBD) and cannabinol (CBN). This information would also allow state governments to regulate medicinal cannabis more effectively and let dispensaries differentiate products for pricing purposes.

Thanks to a boom in interest in medical marijuana, labs are popping up across the U.S. capable of delivering this important information. The laboratories with access to the most advanced technology for testing should capture a significant share of the testing market, says NTRR CEO Cindy Morrissey, because they’ll be better equipped to quickly and efficiently handle large volumes of cannabis.

“Patients use this crucial information to better predict how marijuana will help them, and to be sure that their marijuana is free of harmful pathogens, residue, pesticides and debris, which is important if you’re suffering from a serious illness,” she said. “Growers can use this lab data to monitor and upgrade their cultivation techniques. So, the market is there and growing for these testing innovations, and we’re seeking out potential partners who can help us deliver them.”

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (PINK: PHOT).